Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Annals of Cancer Research and Therapy | journal | 0.192 Q3 | 7 | 8 | 80 | 232 | 28 | 80 | 0.41 | 29.00 | |
52 | Drug Metabolism Reviews | journal | 0.870 Q2 | 108 | 20 | 78 | 2451 | 403 | 78 | 3.73 | 122.55 | |
53 | Drug Resistance Updates | journal | 4.665 Q1 | 132 | 74 | 76 | 6493 | 1477 | 75 | 17.53 | 87.74 | |
54 | OpenNano | journal | 0.824 Q2 | 21 | 80 | 73 | 7983 | 473 | 73 | 6.48 | 99.79 | |
55 | Current Cardiovascular Risk Reports | journal | 0.491 Q3 | 34 | 21 | 72 | 1537 | 119 | 72 | 1.94 | 73.19 | |
56 | PPAR Research | journal | 0.698 Q2 | 59 | 15 | 69 | 877 | 199 | 69 | 3.25 | 58.47 | |
57 | Trends in Immunotherapy | journal | 0.133 Q4 | 4 | 28 | 54 | 1817 | 14 | 51 | 0.24 | 64.89 | |
58 | Topics in antiviral medicine | journal | 0.614 Q2 | 46 | 18 | 36 | 403 | 63 | 36 | 1.89 | 22.39 | |
59 | Cancer Innovation | journal | 0.389 Q3 | 4 | 56 | 20 | 3056 | 23 | 19 | 1.15 | 54.57 | |
60 | Adverse Drug Reaction Bulletin | journal | 0.126 Q4 | 8 | 6 | 18 | 196 | 5 | 18 | 0.17 | 32.67 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®